We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.91%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$115M
(+8.2%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
21.73%
Holding
175
New
30
Increased
50
Reduced
76
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$14.6M |
| 2 |
AMC Entertainment Holdings
AMC
|
+$12.4M |
| 3 |
Installed Building Products
IBP
|
+$9.96M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$9.28M |
| 5 |
ELGX
Endologix Inc
ELGX
|
+$8.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MINI
Mobile Mini Inc
MINI
|
+$17.1M |
| 2 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$15.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$12.2M |
| 4 |
Accuray
ARAY
|
+$11.9M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.11% |
| 2 | Healthcare | 19.65% |
| 3 | Industrials | 15.76% |
| 4 | Communication Services | 10.92% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCAI
126
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $1.79M | 0.12% |
+36,807
| New | +$1.7M |
|
127
SBA Communications
SBAC
$19.2B
| $816K | 0.05% |
7,276
-676
| -9% | -$76.4K |
|
128
SiriusXM
SIRI
$9.97B
| $525K | 0.03% |
12,579
-1,168
| -8% | -$48.8K |
|
129
MGM Resorts International
MGM
$11.4B
| $477K | 0.03% |
18,322
+1,412
| +8% | +$34.3K |
|
130
Bread Financial
BFH
$4.37B
| $440K | 0.03% |
2,570
-238
| -8% | -$40.5K |
|
131
Equifax
EFX
$20.3B
| $425K | 0.03% |
3,159
-293
| -8% | -$38.8K |
|
132
Willis Towers Watson
WTW
$31.7B
| $405K | 0.03% |
3,050
-40,260
| -93% | -$5.01M |
|
133
Vertex Pharmaceuticals
VRTX
$121B
| $380K | 0.03% |
4,357
-405
| -9% | -$38.3K |
|
134
Snap-on
SNA
$21.2B
| $369K | 0.02% |
2,427
-225
| -8% | -$34.8K |
|
135
Expeditors International
EXPD
$22B
| $362K | 0.02% |
7,029
-653
| -9% | -$33.1K |
|
136
Expedia Group
EXPE
$35.4B
| $347K | 0.02% |
2,974
+536
| +22% | +$60.6K |
|
137
Dentsply Sirona
XRAY
$2.68B
| $342K | 0.02% |
5,751
-222
| -4% | -$13.6K |
|
138
Centene
CNC
$30.7B
| $338K | 0.02% |
+10,084
| New | +$350K |
|
139
BioMarin Pharmaceuticals
BMRN
$11.6B
| $306K | 0.02% |
3,305
+326
| +11% | +$30.7K |
|
|
IMS
140
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $306K | 0.02% |
9,763
-385
| -4% | -$11.3K |
|
141
Genpact
G
$5.96B
| $294K | 0.02% |
12,271
+2,466
| +25% | +$61.1K |
|
|
EVHC
142
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $285K | 0.02% |
4,278
+81
| +2% | +$5.58K |
|
|
MBLY
143
DELISTED
Mobileye N.V.
MBLY
| $269K | 0.02% |
6,313
+121
| +2% | +$5.59K |
|
144
Advance Auto Parts
AAP
$3.35B
| $262K | 0.02% |
1,758
-163
| -8% | -$26K |
|
|
WRK
145
DELISTED
WestRock Company
WRK
| $255K | 0.02% |
+5,261
| New | +$235K |
|
|
BEAV
146
DELISTED
B/E Aerospace Inc
BEAV
| $253K | 0.02% |
+4,905
| New | +$237K |
|
147
DaVita
DVA
$15.4B
| $242K | 0.02% |
+3,663
| New | +$258K |
|
|
CXO
148
DELISTED
CONCHO RESOURCES INC.
CXO
| $239K | 0.02% |
+1,738
| New | +$220K |
|
149
JB Hunt Transport Services
JBHT
$25.5B
| $235K | 0.02% |
+2,899
| New | +$237K |
|
150
Aramark
ARMK
$15B
| $232K | 0.02% |
+8,437
| New | +$223K |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Elk Creek Partners held 175 positions worth $1.52B, up 8.2% from $1.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Elk Creek Partners's Q3 2016 filing shows 30 new, 50 increased, 76 reduced and 19 closed positions. Its largest new stake was Ligand Pharmaceuticals: 199,255 shares worth $12.7M. The largest sale was Mobile Mini Inc, an estimated $17.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Elk Creek Partners's largest Q3 2016 buy was Ligand Pharmaceuticals: 199,255 shares worth $12.7M.
- Elk Creek Partners added most to Endologix Inc in Q3 2016, an estimated $8.95M increase.
- Elk Creek Partners's biggest Q3 2016 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $11.7M.
- Elk Creek Partners fully exited Mobile Mini Inc in Q3 2016, selling an estimated $17.1M.
- Elk Creek Partners's ten largest holdings make up 22% of its $1.52B portfolio in Q3 2016.
- Elk Creek Partners opened 30 new positions and closed 19 in Q3 2016.
- Elk Creek Partners's portfolio value rose 8.2% quarter-over-quarter to $1.52B.
Based on Elk Creek Partners's 13F filing for Q3 2016, filed 10 Nov 2016.